1-20 of 28
barrett's esophagus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Sumithira Vasu, MDMBBS, Nelli Bejanyan, MD, Steven Devine, MD, Elizabeth Krakow, MDMSc, Elizabeth Krakow, MD, Brent Logan, PhD, Leo Luznik, MD, Brittany K Ragon, MD, Emma Barrett, MD, Joe Shan, MPH, BS, Richard E. Champlin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1955.
https://doi.org/10.1182/blood-2019-128005
Published: 2019
Journal Articles

Impact of Pre-Engraftment Cytomegalovirus Viraemia in Allogeneic Haematopoetic Stem Cell Transplant Recipients

Joanne L C Tan, MBBS, Shio Yen Tio, MBBS, FRACP, Michelle K Yong, MBBS, FRACP, MPH, PhD, David Ritchie, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5656.
https://doi.org/10.1182/blood-2019-122368
Published: 2019
Journal Articles

Nanoparticles Mimicking Platelets and Platelet Cloaking

Liangfang Zhang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): SCI-38.
https://doi.org/10.1182/blood-2019-121082
Published: 2019
Journal Articles

Development and Use of Clinical Pharmacodynamic Assays to Demonstrate Target Engagement for AZD4573, a Selective and Potent CDK9 Inhibitor Currently in Phase I Clinical Trials

Tammie Yeh, PhD, Greg O'Connor, MS, Justin Cidado, PhD, J. Carl Barrett, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3505.
https://doi.org/10.1182/blood-2018-99-114948
Published: 2018
Journal Articles

CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML

Kristopher Clark, PhD, Edward Ainscow, PhD, Adam Peall, Stuart Thomson, PhD, Andrew Leishman, PhD, Sullivan Elaine, PhD, Simak Ali, PhD, Raoul Coombes, MD, Anthony Barrett, PhD, Ash Kumar Bahl, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2645.
https://doi.org/10.1182/blood.V130.Suppl_1.2645.2645
Published: 2017
Journal Articles

T-ALL Oncogenes Function in the Context of Pre- and Post T-Cell Commitment Programs

Kirsten Canté-Barrett, PhD, Eric Vroegindeweij, PhD, Yunlei Li, PhD, Hans Clevers, MD PhD, Jules Meijerink, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3806.
https://doi.org/10.1182/blood.V130.Suppl_1.3806.3806
Published: 2017
Journal Articles

CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies

Tim Chan, PhD, John Gallagher, Nai-Lin Cheng, PhD, Fernando Carvajal-Borda, DVM, Jacques Plummer, Adeline Govekung, John A Barrett, PhD, Pranay D. Khare, PhD, Laurence J N Cooper, MDPhD, Rutul R Shah
Journal: Blood
Blood (2017) 130 (Supplement 1): 1324.
https://doi.org/10.1182/blood.V130.Suppl_1.1324.1324
Published: 2017
Journal Articles

Longer Term Efficacy and Safety of Subcutaneous Compared with Intravenous Rituximab: Updated Results of the Phase 3 SABRINA Study

Andrew J Davies, FRCP PhD, Biljana Mihaljevic, Santiago Mercadal, MD, Georgi Mihaylov, Sirpa Leppä, Denise Cotting, Klaas Veenstra, Artem Zharkov, Mark Dixon, BSc MSC, Martin Barrett, David Macdonald
Journal: Blood
Blood (2016) 128 (22): 1103.
https://doi.org/10.1182/blood.V128.22.1103.1103
Published: 2016
Journal Articles

Interleukin 6 Is Not Made By Chimeric Antigen Receptor T Cells and Does Not Impact Their Function

David M. Barrett, MD PhD, Nathan Singh, MD, Ted J. Hofmann, PhD, Zachary Gershenson, Stephan A. Grupp, MD PhD
Journal: Blood
Blood (2016) 128 (22): 654.
https://doi.org/10.1182/blood.V128.22.654.654
Published: 2016
Journal Articles

Minimally Ex Vivo Manipulated Gene-Modified T Cells Display Enhanced Tumor Control

Saba Ghassemi, PhD, Patel Prachi, John Scholler, Selene Nunez-Cruz, PhD, David M. Barrett, MD PhD, Felipe Bedoya, PhD, Joseph A. Fraietta, PhD, Simon Francis Lacey, PhD BS, Bruce L Levine, PhD, Stephen A. Grupp, MD PhD, Carl H June, MD, Michael C. Milone, MD PhD, J. Joseph Melenhorst, PhD
Journal: Blood
Blood (2016) 128 (22): 4549.
https://doi.org/10.1182/blood.V128.22.4549.4549
Published: 2016
Journal Articles

Efficacy of Humanized CD19-Targeted Chimeric Antigen Receptor (CAR)-Modified T Cells in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

Shannon L Maude, MD PhD, David M. Barrett, MD PhD, Susan R. Rheingold, MD, Richard Aplenc, MD PhD, David T Teachey, MD, Colleen Callahan, MSN, Diane Baniewicz, MSN, Claire White, BSN, Mala K. Talekar, MD, Pamela A Shaw, PhD, Jennifer L Brogdon, PhD, Regina M Young, PhD, John Scholler, Katherine T. Marcucci, PhD, Bruce L Levine, PhD, Noelle Frey, MD MS, David L Porter, MD, Simon F. Lacey, PhD, J. Joseph Melenhorst, PhD, Carl H June, MD, Stephan A. Grupp, MD PhD
Journal: Blood
Blood (2016) 128 (22): 217.
https://doi.org/10.1182/blood.V128.22.217.217
Published: 2016
Journal Articles

Cars in Leukemia: Relapse with Antigen-Negative Leukemia Originating from a Single B Cell Expressing the Leukemia-Targeting CAR

Simon Francis Lacey, PhD BS, Jun Xu, PhD, Marco Ruella, MD, David M. Barrett, MD PhD, Irina Kulikovskaya, PhD, David E Ambrose, BS, Prachi R. Patel, BS, Tyler Reich, John Scholler, Farzana Nazimuddin, Joseph A. Fraietta, PhD, Shannon L Maude, MD PhD, Saar I. Gill, MD PhD, Bruce L Levine, PhD, Christopher L Nobles, PhD, Frederic D Bushman, PhD, Elena Orlando, PhD, Stephan A. Grupp, MD PhD, Carl H June, MD, Jan Joseph Melenhorst, PhD
Journal: Blood
Blood (2016) 128 (22): 281.
https://doi.org/10.1182/blood.V128.22.281.281
Published: 2016
Journal Articles

Mott cell (Russell body) Barrett's esophagitis

Aruna Rangan, Daniel W. Visscher
Journal: Blood
Blood (2016) 128 (15): 1992.
https://doi.org/10.1182/blood-2016-06-724344
Published: 2016
Journal Articles

The Importance of CD19 Exon 2 for Surface Localization: Closing the Ig-like Loop

Asen Bagashev, PhD, Elena Sotillo, PhD, Glendon Wu, Andrei Thomas-Tikhonenko, PhD
Journal: Blood
Blood (2015) 126 (23): 3433.
https://doi.org/10.1182/blood.V126.23.3433.3433
Published: 2015
Journal Articles

Regulation of CD19 Exon 2 Inclusion in B-Lymphoid Cells By Splicing Factors and Epigenetic Marks

Kathryn Black, PhD, Elena Sotillo, PhD, Nicole Martinez, Matthew Gazzara, Alejandro Barrera, Yoseph Barash, PhD, Kristen Lynch, PhD, Andrei Thomas-Tikhonenko, PhD
Journal: Blood
Blood (2015) 126 (23): 2425.
https://doi.org/10.1182/blood.V126.23.2425.2425
Published: 2015
Journal Articles

Novel Chimeric Antigen Receptor T Cells for the Treatment of CD19-Negative Relapses Occurring after CD19-Targeted Immunotherapies

Marco Ruella, MD, David Barrett, MD PhD, Saad S. Kenderian, MD, Olga Shestova, PhD, Ted J. Hofmann, PhD, John Scholler, Simon F. Lacey, PhD BSc, Jan J Melenhorst, PhD, Farzana Nazimuddin, MS, Michael Kalos, PhD, David L. Porter, MD, Carl H. June, MD, Stephan A. Grupp, MD PhD, Saar I. Gill, MD PhD
Journal: Blood
Blood (2014) 124 (21): 966.
https://doi.org/10.1182/blood.V124.21.966.966
Published: 2014
Journal Articles

Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation

Kristen A McEachern, PhD, Adriana E Tron, PhD, Greg O'Connor, Rachel DuPont, Francis D Gibbons, PhD, Lourdes Pablo, Karthick Vishwanathan, PhD, Patricia McCoon, PhD, Jorge E. Cortes, MD, Daniel J. DeAngelo, MDPhD, Mark D Minden, MDPhD, Geoffrey L. Uy, MD, Frank Neumann, MDPhD, Karen Keating, Dennis Huszar, PhD, J. Elizabeth Pease, PhD, Jeffrey Brown, PhD, J. Carl Barrett, PhD
Journal: Blood
Blood (2014) 124 (21): 906.
https://doi.org/10.1182/blood.V124.21.906.906
Published: 2014
Journal Articles

T Cells Engineered with a Chimeric Antigen Receptor (CAR) Targeting CD19 (CTL019) Have Long Term Persistence and Induce Durable Remissions in Children with Relapsed, Refractory ALL

Stephan A. Grupp, MD PhD, Shannon L Maude, MD PhD, Pamela Shaw, PhD, Richard Aplenc, MD PhD, David M. Barrett, MDPhD, Colleen Callahan, MSN, CRNP, Anne Chew, PhD, Simon F. Lacey, PhD BSc, Bruce L. Levine, PhD, J. Joseph Melenhorst, PhD, Laura Motley, RN, BSN, Susan R. Rheingold, MD, Angela Shen, MD, David T. Teachey, MD, Patricia A. Wood, MD PhD, David L Porter, MD, Carl H. June, MD
Journal: Blood
Blood (2014) 124 (21): 380.
https://doi.org/10.1182/blood.V124.21.380.380
Published: 2014
Journal Articles

Epitope Spreading Is Required for Long-Term Protection Against Acute Lymphoblastic Leukemia

Alix E. Seif, MD MPH, Sumin Jo, BSc, Jennie Altman, BSc, Hamid Bassiri, MD PhD, David M. Barrett, MDPhD, Stephan A. Grupp, MD PhD, Gregor SD Reid, PhD
Journal: Blood
Blood (2014) 124 (21): 3717.
https://doi.org/10.1182/blood.V124.21.3717.3717
Published: 2014
Journal Articles

Pharmacokinetics (PK), Safety and Overall Response Rate (ORR) Achieved with Subcutaneous (SC) Administration of Rituximab in Combination with Chemotherapy Were Comparable to Those Achieved with Intravenous (IV) Administration in Patients (pts) with Follicular Lymphoma (FL) in the First-Line Setting: Stage 1 Results of the Phase III SABRINA Study (BO22334)

Andrew Davies, MD, Francesco Merli, Biljana Mihaljevik, Noppadol Siritanaratkul, MD, Philippe Solal-Céligny, MD, Axel Boehnke, Claude Berge, Christine McIntyre, Martin Barrett, PhD, David Macdonald, MD, FRCPC
Journal: Blood
Blood (2012) 120 (21): 1629.
https://doi.org/10.1182/blood.V120.21.1629.1629
Published: 2012